日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment Patterns and Healthcare Utilization on Pediatric Atopic Dermatitis With Allergic Comorbidities: A Japanese Claims-Based Study

针对伴有过敏性合并症的儿童特应性皮炎的治疗模式和医疗资源利用情况:一项基于日本医疗保险索赔数据的研究

Futamura, Masaki; Kang, Yumi; Singh, Ambrish; Danjo, Junichi; Matsuo, Takashi; Torisu-Itakura, Hitoe; Nagao, Mizuho

Comprehensive proteome profiling of molecular endotypes in Japanese adults with moderate-to-severe atopic dermatitis

对患有中重度特应性皮炎的日本成年人进行分子内型的全面蛋白质组学分析

Serelli-Lee, Victoria; Ozeki, Akichika; Preuss, Christoph; Benschop, Robert J; Torisu-Itakura, Hitoe; Matsuo, Takashi; Sims, Jonathan T

Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance

ixekizumab治疗日本寻常型银屑病、银屑病关节炎、泛发性脓疱型银屑病和红皮病型银屑病患者的安全性和有效性:上市后监测

Torii, Hideshi; Morita, Akimichi; Yamamoto, Chie; Dong, Jiayi; Tsujimoto, Mika; Matsuo, Takashi; Torisu-Itakura, Hitoe; Ohtsuki, Mamitaro; Saeki, Hidehisa

Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis

Lebrikizumab联合局部皮质类固醇可改善日本中重度特应性皮炎患者的患者报告结局

Tanaka, Akio; Igawa, Ken; Takahashi, Hidetoshi; Shimizu, Ryosuke; Kataoka, Yoko; Torisu-Itakura, Hitoe; Morisaki, Yoji; Montmayeur, Sonia; Katoh, Norito

Comparison of Treatment Goals between Users of Biological and Non-Biological Therapies for Treatment of Psoriasis in Japan

日本银屑病生物疗法与非生物疗法使用者治疗目标的比较

Okubo, Yukari; Tang, Ann Chuo; Inoue, Sachie; Torisu-Itakura, Hitoe; Ohtsuki, Mamitaro

Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)

快速皮肤清除与生活质量改善之间的关系:对接受 Ixekizumab 治疗的中重度银屑病日本患者进行的事后分析 (UNCOVER-J)

Honma, Masaru; Cai, Zhihong; Burge, Russel; Zhu, Baojin; Yotsukura, Sohiya; Torisu-Itakura, Hitoe

Long-term efficacy and safety results from an open-label phase III study (UNCOVER-J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab

一项针对日本斑块状银屑病患者的开放标签 III 期研究 (UNCOVER-J) 的长期疗效和安全性结果:停药和重新使用 ixekizumab 的影响

Umezawa, Y; Torisu-Itakura, H; Morisaki, Y; ElMaraghy, H; Nakajo, K; Akashi, N; Saeki, H

Long-term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open-label, phase 3 study (UNCOVER-J)

ixekizumab治疗日本红皮病型或泛发性脓疱型银屑病患者的长期疗效和安全性:一项开放标签3期研究的亚组分析(UNCOVER-J)

Okubo, Y; Mabuchi, T; Iwatsuki, K; Elmaraghy, H; Torisu-Itakura, H; Morisaki, Y; Nakajo, K

Efficacy and safety of ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis: Subgroup analysis of a placebo-controlled, phase 3 study (UNCOVER-1)

ixekizumab治疗中重度斑块状银屑病日本患者的疗效和安全性:一项安慰剂对照3期研究(UNCOVER-1)的亚组分析

Imafuku, Shinichi; Torisu-Itakura, Hitoe; Nishikawa, Atsushi; Zhao, Fangyi; Cameron, Gregory S

Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging

免疫组化分析在结肠癌预后评估中的应用:超分期的新型补充手段

Lavotshkin, Simon; Jalas, John R; Torisu-Itakura, Hitoe; Ozao-Choy, Junko; Lee, Ji Hey; Sim, Myung Shin; Stojadinovic, Alexander; Wainberg, Zev; Bifulco, Carlo B; Fox, Bernard A; Bilchik, Anton J